¼¿ï¼º¸ðº´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö : 2019-11-02±³À°ÀÏÀÚ : 2019-11-02
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿ø ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø
±³À°ÁÖÁ¦ :
´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Á¤º°
¿¬¶ôó : 02-565-3350
À̸ÞÀÏ :
ksh@koreanhypertension.org ±³À°Á¾·ù : ³»°ú, Á¤Çü¿Ü°ú, ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í »çÀüµî·Ï 1¸¸¿ø / ÇöÀåµî·Ï 2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 08:30~08:45 History of pulmonary hypertension ¹ÚÀçÇü(Ãæ³²ÀÇ´ë ¼øȯ±â ³»°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 08:45~09:00 Epidemiology of pulmonary hypertension and suggestion for Korean registry ÀÌÁÖÈñ(ÃæºÏÀÇ´ë ¼øȯ±â ³»°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 09:00~09:15 Genetic evaluation of pulmonary hypertension and its clinical implication ÀÌ¿µÀç(°¡ÃµÀÇ´ë »ýÈÇаú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 09:15~09:30 Combination treatment of selective pulmonary vasodilator for pulmonary hypertension Á¤Á¶¿ø(¿¬¼¼ÀÇ´ë ¼Ò¾Æ½ÉÀå°ú)
Åä·Ð 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 09:30~09:45 Discussion ÃÖ¼ºÀç °í·ÁÀÇ´ë ·ù¸¶Æ¼½º³»°ú/Àå¼ÒÀÍ ¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú/Çã¶õ ÇѾçÀÇ´ë ½ÉÀå³»°ú(ÃÖ¼ºÀç °í·ÁÀÇ´ë ·ù¸¶Æ¼½º³»°ú/Àå¼ÒÀÍ ¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú/Çã¶õ ÇѾçÀÇ´ë ½ÉÀå³»°ú)
ÈÞ½Ä 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 09:45~10:05 Coffee break ()
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 10:05~10:20 CTEPH 2019 Hiromi Matsubara(National Hospital Organization Okayama Medical Center)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 10:20~10:35 Medical devices for pulmonary hypertension ¼ÛÁø¿µ(¼º±Õ°üÀÇ´ë ¼Ò¾Æ½ÉÀå°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 10:35~10:50 Surgical treatment for pulmonary hypertension À±¿µ³²(¿¬¼¼ÀÇ´ë ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 10:50~11:05 Anesthesiology for the patients with pulmonary hypertension À念Àº(¼¿ïÀÇ´ë ¸¶ÃëÅëÁõÀÇÇаú)
Åä·Ð 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 11:05~11:20 Discussion ¼ÕÀϼ® °æÈñÀÇ´ë ¼øȯ±â³»°ú/Àº¿µ¹Î °³²¼¼ºê¶õ½ºº´¿ø ¼Ò¾Æ½ÉÀå°ú/À̼®ÀÎ °¡ÃµÀÇ´ë ÈäºÎ¿Ü°ú(¼ÕÀϼ® °æÈñÀÇ´ë ¼øȯ±â³»°ú/Àº¿µ¹Î °³²¼¼ºê¶õ½ºº´¿ø ¼Ò¾Æ½ÉÀå°ú/À̼®ÀÎ °¡ÃµÀÇ´ë ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 11:20~11:35 Taiwan PH Guideline Kuo Yang Wang(Taichung China Medical University Hospital)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 11:35~11:50 Japan PH Guideline Takeshi Ogo(National Cerebral and Cardiovascular Center)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 11:50~12:05 China PH Guideline Zhi-Cheng Jing(Fu Wai Hospital & National Center for Cardiovascular disease)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 12:05~12:20 Proposed Ideas of EASOPH PH Guideline Wook-Jin Chung(Gachon University Gil Medical Center)
½Ä»ç 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 12:20~13:20 Lunch ()
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 13:20~13:40 Pulmonary hypertension in my life ³ëÁ¤ÀÏ(¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 13:40~14:10 How can we diagnose and treat the patients of Pulmonary Hypertension in Heart Failure Stephan Rosenkranz(University of Cologne)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 14:10~14:40 Could we recommend pregnancy in female PAH patient? Hiromi Matsubara(National Hospital Organization Okayama Medical Center)
Åä·Ð 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 14:40~14:50 Discussion ÃÖÁø¿À ¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú/³ªÁø¿À °í·ÁÀÇ´ë ¼øȯ±â³»°ú/À§Áø °¡ÃµÀÇ´ë ½ÉÀå³»°ú/ÀÌÁÖÈñ ÃæºÏÀÇ´ë ¼øȯ±â³»°ú(ÃÖÁø¿À ¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú/³ªÁø¿À °í·ÁÀÇ´ë ¼øȯ±â³»°ú/À§Áø °¡ÃµÀÇ´ë ½ÉÀå³»°ú/ÀÌÁÖÈñ ÃæºÏÀÇ´ë ¼øȯ±â³»°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 14:50~15:05 Transition of pediatric patient with pulmonary hypertension ±è±â¹ü(¼¿ïÀÇ´ë ¼Ò¾Æ½ÉÀå°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 15:05~15:20 Pregnancy and delivery in the patients with pulmonary hypertension ±è¹ÌÁ¤(°¡Å縯ÀÇ´ë ÀÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 15:20~15:35 Psychosocial support for patients with pulmonary hypertension ÀÌÁ¤(¼¿ïÀÇ´ë ½Å°æÁ¤½Å°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 15:35~15:50 Palliative care for the patients with advanced pulmonary hypertension ±è¹Î¼±(¼¿ïÀÇ´ë ¿ÏÈÀÇ·á)
Åä·Ð 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 15:50~16:05 Discussion ¹ÚÂù¼® °¡Å縯ÀÇ´ë ¼øȯ±â³»°ú/³ª½Â¿ø ¿ï»êÀÇ´ë È£Èí±â³»°ú/¾È°æÁø °¡ÃµÀÇ´ë ¼Ò¾Æû¼Ò³â°ú(¹ÚÂù¼® °¡Å縯ÀÇ´ë ¼øȯ±â³»°ú/³ª½Â¿ø ¿ï»êÀÇ´ë È£Èí±â³»°ú/¾È°æÁø °¡ÃµÀÇ´ë ¼Ò¾Æû¼Ò³â°ú)
ÈÞ½Ä 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 16:05~16:25 Coffee break ()
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 16:25~16:35 PH with uncorrected CHD ¾ÈÈ¿¼ø(¼¿ï´ë º¸¶ó¸Åº´¿ø ¼Ò¾Æ½ÉÀå°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 16:35~16:45 PH with left heart disease Á¤Çý¹®(°æÈñÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 16:45~16:55 PH with connective disease °ÁöÇö(Àü³²ÀÇ´ë ·ù¸¶Æ¼½º³»°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 16:55~17:05 PH with liver disease À念¿ì(°¡ÃµÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 17:05~17:15 PH with lung disease ÀÌÀç½Â(¼¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)
±³À°½Ã°£ 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 17:15~17:25 PH with post-operative CHD À±ÀÚ°æ(¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú)
Åä·Ð 11-02 ¼¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °´ç 17:25~17:45 Discussion À¯½Â±â À»ÁöÀÇ´ë ¼øȯ±â³»°ú/¼Çý¼± ¼øõÇâÀÇ´ë ¼øȯ±â³»°ú/±è¼öÇö ¼¿ïÀÇ·á¿ø È£Èí±â³»°ú(À¯½Â±â À»ÁöÀÇ´ë ¼øȯ±â³»°ú/¼Çý¼± ¼øõÇâÀÇ´ë ¼øȯ±â³»°ú/±è¼öÇö ¼¿ïÀÇ·á¿ø È£Èí±â³»°ú)